DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,504 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,962,000 | +37.8% | 20,000 | +33.3% | 3.39% | +163.6% |
Q2 2023 | $3,600,000 | -50.7% | 15,000 | -48.3% | 1.29% | -69.7% |
Q1 2023 | $7,309,160 | +37.7% | 29,000 | +45.0% | 4.25% | +59.1% |
Q4 2022 | $5,308,400 | -48.6% | 20,000 | -50.0% | 2.67% | -56.9% |
Q3 2022 | $10,332,000 | +85.3% | 40,000 | +81.8% | 6.19% | +61.9% |
Q2 2022 | $5,577,000 | -49.7% | 22,000 | -41.8% | 3.82% | +6.2% |
Q1 2022 | $11,088,000 | -61.7% | 37,800 | -57.0% | 3.60% | -26.6% |
Q4 2021 | $28,953,000 | -3.9% | 88,000 | -11.1% | 4.91% | +5.0% |
Q3 2021 | $30,140,000 | +24.8% | 99,000 | +10.0% | 4.67% | +6.0% |
Q2 2021 | $24,152,000 | +123.5% | 90,000 | +87.5% | 4.41% | +128.5% |
Q1 2021 | $10,804,000 | -6.1% | 48,000 | -7.3% | 1.93% | -11.2% |
Q4 2020 | $11,507,000 | -3.2% | 51,800 | -6.2% | 2.17% | -35.5% |
Q3 2020 | $11,886,000 | -29.2% | 55,200 | -41.9% | 3.37% | -24.0% |
Q2 2020 | $16,799,000 | +10.3% | 95,000 | -13.6% | 4.43% | +12.5% |
Q1 2020 | $15,225,000 | -33.9% | 110,000 | -26.7% | 3.94% | -0.4% |
Q4 2019 | $23,022,000 | -20.3% | 150,000 | -25.0% | 3.96% | -22.2% |
Q3 2019 | $28,886,000 | – | 200,000 | – | 5.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |